Archive 2016 2016 - 16 Dec 2016 – 21st Century Cures Act signed into law by President Obama - 30 Nov 2016 – Destiny Pharma CEO appointed to the board of GAMRIF - 31 Oct 2016 – Wellcome Trust report on boosting development of new antimicrobial drugs - Destiny Pharma to attend IDWeek in New Orleans, Louisiana - 21 Sep 2016 – Momentous Step taken by UN to Fight Antibiotic Resistance welcomed by Destiny Pharma - 05 Sep 2016 – Press Release: Novel Antibacterial Drug, exeporfinium chloride, Delivers Encouraging Safety, Tolerability and Efficacy Data in US Clinical Trial - Destiny Pharma Expert View Published in The Pharma Letter - Destiny Pharma invited to present at the inaugural Superbugs & Superdrugs USA Conference & Exhibition on the 14th and 15th November 2016 in New Jersey, USA - 19 May 2016 – Destiny Pharma Welcomes O’Neill Report on Tackling Antimicrobial Resistance (AMR) - 18 Mar 2016 – Destiny Pharma: ‘In the News.’ - 26 Jan 2016 – Destiny Pharma sign Declaration to fight antibiotic resistance Archive 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
